Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M307265200 on September 23, 2003

J. Biol. Chem., Vol. 278, Issue 48, 47762-47775, November 28, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/48/47762    most recent
M307265200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Babbar, N.
Right arrow Articles by Gerner, E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Babbar, N.
Right arrow Articles by Gerner, E. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cyclooxygenase-independent Induction of Apoptosis by Sulindac Sulfone Is Mediated by Polyamines in Colon Cancer*

Naveen Babbar{ddagger}§, Natalia A. Ignatenko{ddagger}, Robert A. Casero, Jr.||, and Eugene W. Gerner{ddagger}§¶**

From the {ddagger}Arizona Cancer Center, the §Biochemistry, Molecular and Cellular Biology Graduate Program, and the Department of Cell Biology and Anatomy, The University of Arizona, Tucson, Arizona 85724 and ||The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231

Sulindac, a non-steroidal anti-inflammatory prodrug, is metabolized into pharmacologically active sulfide and sulfone derivatives. Sulindac sulfide, but not sulindac sulfone, inhibits cyclooxygenase (COX) enzyme activities, yet both derivatives have growth inhibitory effects on colon cancer cells. Microarray analysis was used to detect COX-independent effects of sulindac on gene expression in human colorectal cells. Spermidine/sperm-ine N1-acetyltransferase (SSAT) gene, which encodes a polyamine catabolic enzyme, was induced by clinically relevant sulindac sulfone concentrations. Northern blots confirmed increased SSAT RNA levels in these colon cancer cells. Deletion analysis and mutational studies were done to map the sulindac sulfone-dependent response sequences in the SSAT 5'-flanking sequences. This led us to the identification of two peroxisome proliferator-activated receptor (PPAR) response elements (PPREs) in the SSAT gene. PPRE-2, at +48 bases relative to the transcription start site, is required for the induction of SSAT by sulindac sulfone and is specifically bound by PPAR{gamma} in the Caco-2 cells as shown by transfection and gel shift experiments. PPRE-1, at–323 bases relative to the start site, is not required for the induction of SSAT by sulindac sulfone but can be bound by both PPAR{delta} and PPAR{gamma}. Sulindac sulfone reduced cellular polyamine contents in the absence but not in the presence of verapamil, an inhibitor of the export of monoacetyl diamines, inhibited cell proliferation and induced apoptosis. The induced apoptosis could be partially rescued by exogenous putrescine. These data suggest that apoptosis induced by sulindac sulfone is mediated, in part, by the COX-independent, PPAR-dependent transcriptional activation of SSAT, leading to reduced tissue polyamine contents in human colon cancer cells.


Received for publication, July 7, 2003 , and in revised form, September 9, 2003.

* This work was supported by National Institutes of Health Grants CA23074, CA72008, CA51085, and CA95060 and Arizona Disease Control Research Commission (ADCRC) Contract No. 1516. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** To whom correspondence should be addressed: Arizona Cancer Center, 1515 N. Campbell Ave., P. O. Box 245024, Tucson, AZ 85724. Tel.: 520-626-2197; Fax: 520-626-4480; E-mail: egerner{at}azcc.arizona.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
E. W. Gerner and F. L. Meyskens Jr.
Combination Chemoprevention for Colon Cancer Targeting Polyamine Synthesis and Inflammation
Clin. Cancer Res., February 1, 2009; 15(3): 758 - 761.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. E. Pegg
Spermidine/spermine-N1-acetyltransferase: a key metabolic regulator
Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E995 - E1010.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. A. Hubner, K. R. Muir, J.-F. Liu, R. F.A. Logan, M. J. Grainge, R. S. Houlston, and Members of the UKCAP Consortium
Ornithine Decarboxylase G316A Genotype Is Prognostic for Colorectal Adenoma Recurrence and Predicts Efficacy of Aspirin Chemoprevention
Clin. Cancer Res., April 15, 2008; 14(8): 2303 - 2309.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Wang, D. J. Feith, P. Welsh, C. S. Coleman, C. Lopez, P. M. Woster, T. G. O'Brien, and A. E. Pegg
Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesis
Carcinogenesis, November 1, 2007; 28(11): 2404 - 2411.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Jell, S. Merali, M. L. Hensen, R. Mazurchuk, J. A. Spernyak, P. Diegelman, N. D. Kisiel, C. Barrero, K. K. Deeb, L. Alhonen, et al.
Genetically Altered Expression of Spermidine/Spermine N1-Acetyltransferase Affects Fat Metabolism in Mice via Acetyl-CoA
J. Biol. Chem., March 16, 2007; 282(11): 8404 - 8413.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. L. R. Barry, J. A. Baron, S. Bhat, M. V. Grau, C. A. Burke, R. S. Sandler, D. J. Ahnen, R. W. Haile, and T. G. O'Brien
Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
J Natl Cancer Inst, October 18, 2006; 98(20): 1494 - 1500.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Babbar, A. Hacker, Y. Huang, and R. A. Casero Jr.
Tumor Necrosis Factor {alpha} Induces Spermidine/Spermine N1-Acetyltransferase through Nuclear Factor {kappa}Bin Non-small Cell Lung Cancer Cells
J. Biol. Chem., August 25, 2006; 281(34): 24182 - 24192.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Ulrich, S. M. Loitsch, O. Rau, A. von Knethen, B. Brune, M. Schubert-Zsilavecz, and J. M. Stein
Peroxisome Proliferator-Activated Receptor {gamma} as a Molecular Target of Resveratrol-Induced Modulation of Polyamine Metabolism.
Cancer Res., July 15, 2006; 66(14): 7348 - 7354.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G. M. Pitari, T. Li, R. I. Baksh, and S. A. Waldman
Exisulind and guanylyl cyclase C induce distinct antineoplastic signaling mechanisms in human colon cancer cells
Mol. Cancer Ther., May 1, 2006; 5(5): 1190 - 1196.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
Y. Wang and R. A. Casero Jr.
Mammalian Polyamine Catabolism: A Therapeutic Target, a Pathological Problem, or Both?
J. Biochem., January 1, 2006; 139(1): 17 - 25.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
U. K. Basuroy and E. W. Gerner
Emerging Concepts in Targeting the Polyamine Metabolic Pathway in Epithelial Cancer Chemoprevention and Chemotherapy
J. Biochem., January 1, 2006; 139(1): 27 - 33.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Deguchi, S. W. Xing, I. Shureiqi, P. Yang, R. A. Newman, S. M. Lippman, S. J. Feinmark, B. Oehlen, and I. B. Weinstein
Activation of Protein Kinase G Up-regulates Expression of 15-Lipoxygenase-1 in Human Colon Cancer Cells
Cancer Res., September 15, 2005; 65(18): 8442 - 8447.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. M. Tucker, J. T. Murphy, N. Kisiel, P. Diegelman, K. W. Barbour, C. Davis, M. Medda, L. Alhonen, J. Janne, D. L. Kramer, et al.
Potent Modulation of Intestinal Tumorigenesis in Apcmin/+ Mice by the Polyamine Catabolic Enzyme Spermidine/Spermine N1-acetyltransferase
Cancer Res., June 15, 2005; 65(12): 5390 - 5398.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Yao, W. Zhou, S. Sangha, A. Albert, A. J. Chang, T. C. Liu, and M. M. Wolfe
Effects of Nonselective Cyclooxygenase Inhibition with Low-Dose Ibuprofen on Tumor Growth, Angiogenesis, Metastasis, and Survival in a Mouse Model of Colorectal Cancer
Clin. Cancer Res., February 15, 2005; 11(4): 1618 - 1628.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. J. Feith, D. K. Bol, J. M. Carboni, M. J. Lynch, S. Sass-Kuhn, P. L. Shoop, and L. M. Shantz
Induction of Ornithine Decarboxylase Activity Is a Necessary Step for Mitogen-Activated Protein Kinase Kinase-Induced Skin Tumorigenesis
Cancer Res., January 15, 2005; 65(2): 572 - 578.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. Wolter, S. Ulrich, and J. Stein
Molecular Mechanisms of the Chemopreventive Effects of Resveratrol and Its Analogs in Colorectal Cancer: Key Role of Polyamines?
J. Nutr., December 1, 2004; 134(12): 3219 - 3222.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement